Huaxi Holdings Company Limited (1689.HK)
HKD 0.67
(0.0%)
HKD 0.67
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -31.47 Million HKD | -313.5% |
| 2022 | -47.08 Million HKD | -87.71% |
| 2021 | 60.79 Million HKD | -36.12% |
| 2020 | 132.66 Million HKD | -3.08% |
| 2019 | 147.88 Million HKD | 99.57% |
| 2018 | 65.83 Million HKD | 31.37% |
| 2017 | 49.86 Million HKD | -16.21% |
| 2016 | 57.12 Million HKD | -22.91% |
| 2015 | 64.68 Million HKD | -10.97% |
| 2014 | 86.53 Million HKD | 16.86% |
| 2013 | 84.07 Million HKD | 25.75% |
| 2012 | 63.62 Million HKD | 53.73% |
| 2011 | 40.17 Million HKD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -2.76 Million HKD | 90.47% |
| 2024 Q2 | -2.76 Million HKD | -479.07% |
| 2023 Q3 | -7.9 Million HKD | -825.64% |
| 2023 Q4 | -22.32 Million HKD | -182.23% |
| 2023 FY | - HKD | -313.5% |
| 2023 Q2 | 1.09 Million HKD | 363.83% |
| 2023 Q1 | 235 Thousand HKD | 101.37% |
| 2022 Q3 | -6.95 Million HKD | -76.16% |
| 2022 FY | - HKD | -87.71% |
| 2022 Q4 | -17.09 Million HKD | -145.69% |
| 2022 Q2 | -3.95 Million HKD | -43.19% |
| 2022 Q1 | -2.75 Million HKD | -114.26% |
| 2021 Q1 | 24.67 Million HKD | -61.43% |
| 2021 Q4 | 19.35 Million HKD | 110.07% |
| 2021 Q3 | 9.21 Million HKD | -81.65% |
| 2021 Q2 | 50.2 Million HKD | 103.43% |
| 2021 FY | - HKD | -36.12% |
| 2020 Q4 | 63.97 Million HKD | 102.73% |
| 2020 Q1 | 29.41 Million HKD | -15.76% |
| 2020 FY | - HKD | -3.08% |
| 2020 Q2 | 59.96 Million HKD | 103.87% |
| 2020 Q3 | 31.55 Million HKD | -47.37% |
| 2019 FY | - HKD | 99.57% |
| 2019 Q4 | 34.91 Million HKD | 0.0% |
| 2019 Q2 | 13.42 Million HKD | -62.41% |
| 2019 Q1 | 35.71 Million HKD | 102.36% |
| 2018 Q4 | 17.64 Million HKD | -38.71% |
| 2018 Q3 | 28.79 Million HKD | 0.0% |
| 2018 FY | - HKD | 31.37% |
| 2018 Q1 | 13.15 Million HKD | 0.0% |
| 2017 Q3 | 11.69 Million HKD | 0.0% |
| 2017 FY | - HKD | -16.21% |
| 2017 Q2 | 11.69 Million HKD | -13.43% |
| 2017 Q4 | 13.15 Million HKD | 12.51% |
| 2017 Q1 | 13.5 Million HKD | 0.0% |
| 2016 Q3 | 15.05 Million HKD | 0.0% |
| 2016 Q2 | 15.05 Million HKD | -2.63% |
| 2016 Q4 | 13.5 Million HKD | -10.26% |
| 2016 FY | - HKD | -22.91% |
| 2016 Q1 | 15.46 Million HKD | 0.0% |
| 2015 Q2 | 16.88 Million HKD | -28.18% |
| 2015 Q1 | 23.5 Million HKD | 0.0% |
| 2015 FY | - HKD | -10.97% |
| 2015 Q4 | 15.46 Million HKD | -8.42% |
| 2015 Q3 | 16.88 Million HKD | 0.0% |
| 2014 Q3 | 19.76 Million HKD | 0.0% |
| 2014 Q2 | 19.76 Million HKD | -7.16% |
| 2014 Q1 | 21.28 Million HKD | 0.0% |
| 2014 FY | - HKD | 16.86% |
| 2014 Q4 | 23.5 Million HKD | 18.95% |
| 2013 FY | - HKD | 25.75% |
| 2013 Q1 | 16.2 Million HKD | 0.0% |
| 2013 Q2 | 11.26 Million HKD | -30.52% |
| 2013 Q3 | 30.24 Million HKD | 168.63% |
| 2013 Q4 | 21.28 Million HKD | -29.63% |
| 2012 Q3 | 17 Million HKD | 19.64% |
| 2012 FY | - HKD | 53.73% |
| 2012 Q4 | 16.2 Million HKD | -4.67% |
| 2012 Q2 | 14.21 Million HKD | 0.0% |
| 2011 FY | - HKD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Starlite Holdings Limited | 71.42 Million HKD | 144.07% |
| Litu Holdings Limited | 1.21 Million HKD | 2697.277% |
| Touyun Biotech Group Limited | -228.56 Million HKD | 86.228% |
| Champion Alliance International Holdings Limited | 35.89 Million HKD | 187.69% |